Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A”

935 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 935 results

Not applicableStudy completedNCT02581969
What this trial is testing

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."

Who this might be right for
Hemophilia A
Bayer 43
Not applicableStudy completedNCT03054662
What this trial is testing

Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.

Who this might be right for
HaemophiliaDeveloping Countries
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 142
Testing effectiveness (Phase 2)Study completedNCT02576795
What this trial is testing

Gene Therapy Study in Severe Haemophilia A Patients (270-201)

Who this might be right for
Severe Haemophilia A
BioMarin Pharmaceutical 15
Large-scale testing (Phase 3)Study completedNCT03974113
What this trial is testing

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 32
Not applicableStudy completedNCT02740413
What this trial is testing

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Who this might be right for
Hemophilia AHemophilia B
Pfizer 86
Not applicableStudy completedNCT00710619
What this trial is testing

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 52
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Not applicableStudy completedNCT04334057
What this trial is testing

Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®

Who this might be right for
Haemophilia A
Novo Nordisk A/S 23
Post-approval studies (Phase 4)Study completedNCT00357656
What this trial is testing

Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

Who this might be right for
Hemophilia A
Baxalta now part of Shire 85
Not applicableEnrolling By InvitationNCT06285071
What this trial is testing

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Who this might be right for
Haemophilia AHaemophilia B
Novo Nordisk A/S 23
Not applicableWithdrawnNCT01051544
What this trial is testing

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center
Not applicableUnknownNCT01303900
What this trial is testing

Cardiovascular Disease (CVD) in Haemophilia

Who this might be right for
HaemophiliaCardiovascular Disease
UMC Utrecht 750
Not applicableStudy completedNCT01000844
What this trial is testing

Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency

Who this might be right for
Hemophilia
University of Colorado, Denver 11
Early research (Phase 1)Study completedNCT04878731
What this trial is testing

Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia

Who this might be right for
Severe Hemophilia
Pfizer 6
Not applicableStudy completedNCT06357572
What this trial is testing

Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystem

Who this might be right for
Hemophilia A With InhibitorHemophilia A
Enzyre B.V. 6
Post-approval studies (Phase 4)Study completedNCT00749476
What this trial is testing

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 1
Large-scale testing (Phase 3)Active Not RecruitingNCT06738485
What this trial is testing

Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products

Who this might be right for
Congenital Hemophilia A
CSL Behring 60
Post-approval studies (Phase 4)Study completedNCT00092976
What this trial is testing

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 15
Post-approval studies (Phase 4)Study completedNCT03093480
What this trial is testing

Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)

Who this might be right for
Hemophilia A With Inhibitors
Bioverativ, a Sanofi company 16
Large-scale testing (Phase 3)Study completedNCT01480180
What this trial is testing

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 186
Next Page